Best Middlesex County Grants for Nonprofits in New Jersey

The New Jersey Commission on Spinal Cord Research offers Individual Research Grants to foster innovative research aimed at developing interventions and cures for paralysis caused by spinal cord injuries. With funding up to $200,000 annually, the program encourages independent investigators and established scientists from other fields to contribute to spinal cord research. The initiative aims to support collaborative efforts and nurture upcoming researchers, ultimately advancing the knowledge and treatment of spinal cord conditions.

The Shore Protection Program in New Jersey aims to safeguard coastal areas from storm damage, erosion, and sea-level rise. It funds projects like beach replenishment and bulkhead construction, prioritizing initiatives that enhance public access and align with state resiliency efforts. Eligible applicants include municipalities and counties, with a minimum local cost share of 25% required. This program is crucial for maintaining New Jersey's coastline and protecting vital infrastructure from natural threats.

The Anderson Foundation for Autism Grant supports organizations aiming to enhance the quality of life for individuals with autism. Grants of up to $50,000 are available for qualified 501(c)(3) organizations, enabling them to implement impactful programs. The foundation not only funds its own initiatives but also extends support to other entities dedicated to similar goals. This initiative emphasizes a collaborative approach to improving autism care and support.

The New Jersey Commission on Spinal Cord Research offers a Postdoctoral & Graduate Student Fellowship aimed at supporting innovative research in spinal cord injury. Funded by the New Jersey Department of Health, this fellowship encourages promising researchers to contribute to advancements in treatment and rehabilitation for spinal cord injuries, ultimately improving patient outcomes and quality of life in the community.

The Hazardous Discharge Site Remediation Fund provides grants and loans to public and private entities for the assessment, investigation, and cleanup of hazardous substance discharges at brownfield sites. Established in 1993, it aims to support redevelopment efforts by covering 100% of assessment costs and up to 75% of remedial action costs. Funded by a portion of the New Jersey Corporate Business Tax, it fosters collaboration between the Department of Environmental Protection and the Economic Development Authority.

The Data-Driven Reporting Project (DDRP) supports local news journalists and freelancers in the US and Canada, focusing on document-based investigative projects for underrepresented communities. It provides financial awards up to $35,000, covering 80% of project costs, along with specialized training on Google Journalist Studio tools. Recipients are encouraged to share their core source documents post-publication to benefit the journalism community. Applications are open to small to midsize newsrooms and freelance journalists with proven track records.

The Technology Initiative Grant (TIG) program by the Legal Services Corporation aims to enhance legal services for low-income populations through innovative technology. It encourages partnerships with justice organizations and supports projects that improve service delivery and efficiency. With a minimum funding request of $40,000, the program seeks to implement new strategies or enhance existing technologies to provide high-quality legal assistance. The initiative fosters replication of successful methodologies from previous projects and other sectors.

LSC’s Basic Field Grants aim to enhance access to civil legal services for low-income individuals across the U.S. and territories. These grants support eligible organizations for up to three years through a competitive application process. The funding is allocated to specific service areas, which change annually, and focuses on providing comprehensive legal assistance. The program includes three types of service areas, ensuring diverse populations, including agricultural and Native American communities, receive necessary legal support.

The Vilcek Foundation's 2026 Prizes for Creative Promise in Fashion & Design and Fashion & Culture will award six $50,000 prizes to young immigrant professionals. This initiative recognizes early- and mid-career creatives in fields such as fashion design, writing, and styling, highlighting the vital contributions of immigrants to the arts in the U.S. Eligible applicants must have at least five years of experience and intend to pursue their careers in the country.

The Green Acres Nonprofit Grant in New Jersey supports tax-exempt organizations aiming to enhance public access to open space for recreation and conservation. This grant fosters the development of outdoor recreational facilities and the stewardship of natural resources. Eligible nonprofits can receive matching funds to acquire land, develop parks, or manage conservation projects, thus ensuring a lasting impact on community well-being and environmental sustainability.

The National Cancer Institute (NCI) seeks to enhance the validation of biomarkers and assays for cancer detection and treatment through its UH3 funding mechanism. This initiative supports multi-disciplinary collaborations to validate existing assays over three years using clinical trial specimens. Emphasis is placed on harmonizing laboratory tests and validating pharmacodynamic markers. Projects should not focus on early-stage technology development but aim for integration into clinical studies as investigational assays.

This funding opportunity invites renewal applications for existing NINDS-supported clinical trial cooperative agreements (U01) that require additional time and resources. The National Institute of Neurological Disorders and Stroke (NINDS) expects applicants to request only what is necessary for trial completion, without introducing new aims. Discussions with NINDS prior to submission are encouraged. Eligible applications must be renewals of previously approved cooperative agreements under specified NIH funding announcements.

This funding opportunity invites applications for pilot projects focused on understudied proteins linked to rare diseases. The goal is to generate preliminary data and tools related to these proteins, which belong to druggable families with known rare disease associations. By supporting innovative research, this initiative aims to facilitate the characterization of these proteins, ultimately contributing to advancements in understanding and treating rare diseases.

This Funding Opportunity Announcement (FOA) aims to advance the identification and evaluation of candidate biomarkers for neurological and neuromuscular disorders. By facilitating the clinical development of neurotherapeutics, the FOA encourages research that includes both animal studies and preliminary human evaluations. The ultimate goal is to produce biomarkers ready for rigorous analytical and clinical validation, enhancing the effectiveness of treatments in clinical practice.

The Limited Competition: Basic Instrumentation Grant (BIG) Program offers funding to NIH-supported researchers for purchasing specialized instruments or integrated systems, with minimum awards of $25,000 and maximum awards reaching $350,000. Eligibility is restricted to institutions that have not received significant S10 funding in recent years. This program aims to enhance research capabilities by providing access to essential technology, thereby fostering scientific innovation and collaboration within the NIH community.

The Shared Instrumentation Grant (SIG) Program supports NIH-funded investigators in acquiring high-cost, specialized instruments, with a minimum award of $50,000 and a maximum of $750,000. Eligible instruments include light microscopes, mass spectrometers, and DNA sequencers, among others. This program aims to enhance research capabilities by enabling the purchase or upgrade of essential equipment for scientific advancement.

The High-End Instrumentation (HEI) Grant Program, offered by the NIH, invites applications for purchasing or upgrading high-end, specialized instruments, with a minimum award of $750,001 and a maximum of $2,000,000. This program supports NIH investigators aiming to enhance their research capabilities through advanced technologies such as mass spectrometers and electron microscopes. Applications must be submitted by 5:00 pm local time of the applicant organization.

The NIH is seeking innovative computational approaches to enhance the curation of biomedical research assets at scale. This initiative aims to accelerate access to secure datasets and computational models, facilitating transformative discoveries in biomedical science. Key deadlines for applications range from January 2025 to January 2027, covering standard, renewal, and AIDS-related grants. Applicants are encouraged to submit Letters of Intent 30 days prior to application deadlines to ensure a streamlined review process.

The Reboot Representation Tech Coalition aims to significantly increase the number of Black, Latina, and Native American women earning computing bachelor’s degrees. They invite qualified organizations to submit grant inquiries focused on recruiting and retaining these women in tech. Programs that leverage existing resources and operate across multiple regions will be prioritized, and the Coalition seeks initiatives backed by substantial research and community trust.

The Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program, funded by the NIH, aims to enhance the biomedical research landscape by supporting resource-limited organizations. It targets domestic institutions with limited research resources and few doctoral students in biomedical fields, promoting broader participation in research and boosting administrative capacities for sponsored programs. Applications are due by 5:00 PM local time of the applicant organization, ensuring timely submissions.

This grant opportunity from the NIH aims to enhance mechanistic research on precision probiotic therapies through a biphasic R61/R33 award mechanism. It encourages innovative studies to identify specific biological factors influencing probiotic responses, thereby improving clinical outcomes. The program supports up to five years of research, with the initial phase focused on discovering unique host characteristics and the second phase assessing improvements in probiotic efficacy through rigorous studies.

This funding opportunity aims to advance mechanistic research for precision probiotic therapies. It invites R33 applications focused on characterizing individual differences in probiotic responses, identifying responder subgroups, and enhancing clinical outcomes. The goal is to develop strategies addressing barriers to effective probiotic use, accounting for human variability. Proposals should include innovative studies using animal models or human subjects, supported by preliminary data to test biological patterns and their effects on health outcomes.

The Extramural Discovery Science Accelerator Award supports the commercialization of ongoing cancer research projects, focusing on experiments that facilitate technology validation and de-risking. Applications are accepted on a rolling basis, with a budget of up to $75,000 for one year. This award encourages independent investigators at any career stage to advance their technologies, with a strong emphasis on commercial viability and collaboration within a learning community.

The Leukemia Exploration and Prevention Grant Program (LEAP) aims to advance cancer interception and prevention for patients with RUNX1 familial platelet disorder (RUNX1-FPD). This program supports interdisciplinary research teams investigating the mechanisms of leukemogenesis and innovative treatment strategies. With funding of up to $430,000 per year, LEAP encourages projects focused on both understanding clonal evolution and developing novel therapeutic approaches. The initiative seeks to bridge critical knowledge gaps and provide urgent interventions for high-risk populations.

The Leukemia Exploration and Prevention Grant Program (LEAP) aims to advance cancer interception and prevention strategies for patients with RUNX1 familial platelet disorder. This initiative, supported by the American Cancer Society, focuses on understanding the mechanisms behind leukemia development and fostering innovative research leading to effective treatment options. Grants of up to $215,000 per year for four years are available, emphasizing the urgent need for targeted therapies in high-risk populations.

The Green Chemistry Student Chapter Award recognizes ACS student chapters for their commitment to green chemistry initiatives. This award highlights the importance of green chemistry in education, encouraging students to engage in activities that promote sustainability. Eligible chapters must submit detailed summaries of at least three green chemistry projects, demonstrating their understanding of the principles and practices that contribute to a more sustainable future.

The CCRP Initiative invites applications for basic research on chemical threats affecting the nervous system, including chemical warfare agents and toxic industrial chemicals. This funding aims to elucidate toxicity mechanisms, explore new toxic exposure manifestations, and identify targets for therapeutic development. Proposals should generate data relevant to understanding these toxic threats, with applications due by 5 PM local time. Optional Letters of Intent are encouraged 30 days prior to the proposal deadline.